Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for EW, sign up here.
Income Statement
Revenue
$6.0bn
Gross Profit
$4.6bn
Earning before Tax
$1.6bn
Net Income
$1.4bn
Net Income Common Shareholders
$1.4bn
EPS
2.31
Balance Sheet
Cash
$1.1bn
Debt
$694.9m
Assets
$9.4bn
Liabilities
$2.6bn
Equity
$6.7bn
Enterprise Value
$45.5bn
Cash Flow Statement
Net Cash from Operations
$895.8m
Net Cash from Investing
$173.8m
Net Cash from Financing
$-0.7bn
Net Cash Flow
$375.4m
Free Cash Flow
$642.8m
Free Cash Flow per Share
$1.06
Metrics
Price to Equity
32.95
Price to Equity (Damodaran)
33.01
Price to Book
6.95
Net Margin
0.23
Return on Equity
0.22
Return on Sales
0.27
Get immediate access to 5-years of reference grade data for EW for free.
Sign upEdwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient''s heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Company Info
Industry
Medical Devices
Employees
19,800
Address
One Edwards Way
Irvine, CA 92614
United States
Phone
949 250 2500
Website
Last Updated
2024-02-16
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.